Bank7 Corp. (NASDAQ:BSVN – Get Free Report) announced a quarterly dividend on Wednesday, August 19th. Investors of record on Friday, September 18th will be given a dividend of 0.30 per share on Thursday, October 8th. This represents a c) annualized dividend and a yield of 2.2%. The ex-dividend date is Friday, September 18th. This is a 11.1% increase from Bank7’s previous quarterly dividend of $0.27.
Bank7 has increased its dividend by an average of 0.2%per year over the last three years and has increased its dividend every year for the last 5 years. Bank7 has a dividend payout ratio of 29.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Bank7 to earn $4.55 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 26.4%.
Bank7 Stock Down 0.2%
NASDAQ:BSVN opened at $55.13 on Wednesday. The stock has a fifty day simple moving average of $51.70 and a 200 day simple moving average of $46.32. The firm has a market capitalization of $525.39 million, a price-to-earnings ratio of 12.62 and a beta of 0.87. Bank7 has a 1-year low of $38.29 and a 1-year high of $57.67.
Bank7 Company Profile
Bank7 is the principal banking subsidiary of Bank7 Corp., a full-service commercial bank headquartered in Oklahoma City, Oklahoma. The company provides banking services to businesses, professionals and individual customers, with an emphasis on relationship-based commercial banking.
Its products and services include business and personal checking and savings accounts, certificates of deposit, treasury management and other cash-management solutions. Bank7 also offers commercial real estate, commercial and industrial, energy, construction, residential mortgage and consumer loans.
Bank7 primarily serves customers in Oklahoma and selected surrounding markets.
Recommended Stories
- Five stocks we like better than Bank7
- 2 “Cheap for a Reason” Airline Stocks That May Be Worth the Risk
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Receive News & Ratings for Bank7 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank7 and related companies with MarketBeat.com's FREE daily email newsletter.
